State of the Medtech, Diagnostics & Digital Health landscape in Q1 2025
In this first update of 2025, we outline the investment landscape and activity in MedTech, Diagnostics, and Digital Health over Q1. We discuss the overall increase in capital, more deals at the expense of median tickets, and most funding rounds going to digital health and IVD with some collaborations still in underserved applications. We also highlight two interesting deals made in the past three months.
